|
May 14
|
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2024
|
|
Apr 9
|
ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor Conference
|
|
Apr 8
|
ESSA Pharma (NASDAQ:EPIX) Is In A Strong Position To Grow Its Business
|
|
Mar 8
|
ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERS
|
|
Jan 22
|
ESSA Pharma Inc.'s (NASDAQ:EPIX) hedge funds investors lost 12% last week but have benefitted from longer-term gains
|
|
Dec 21
|
These Stocks under $10 Are Poised To Explode
|
|
Dec 20
|
EPIX: Initial Data from Combination Trial of Masofaniten and Enzalutamide Expected in 2024…
|